A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

A recent study published in JAMA Network Open evaluated the cost-effectiveness of monoclonal antibodies (mAbs) as pre-exposure prophylaxis (PrEP) for coronavirus disease 2019 (COVID-19). Study: Health ...

A new ad campaign from the AIDS Healthcare Foundation has kicked off another round of controversy about HIV pre-exposure prophylaxis, better known as PrEP. AHF argues that the scientific evidence does ...

A patient with AIDS at a community hospital in the Central African Republic. Sub-Saharan Africa has high rates of HIV infection -- and was the location for a trial testing the effectiveness of a new ...

ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...

PrEP is highly effective, but many women aren’t included in the conversation. Experts say awareness and access must improve.

A drug which reduces the risk of HIV is "extremely effective," a new study has affirmed as experts called for the drug to be used more widely. The study, which helped inform the widespread use of the ...